http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1120418-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 1999-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_280766f6460e6696f81a42db13d81d61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d9c292dcff1367e1051c53de0735515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19cfc7c8e9b2ae82c43e87a948cc5f46 |
| publicationDate | 2001-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1120418-A1 |
| titleOfInvention | Fused pyridazine compounds, process for the preparation of the same and uses thereof |
| abstract | A compound represented by the formula:n nwherein Ring A is a ring represented by the formula:n n(wherein R 1a is a hydrogen atom, a halogen atom, anhydrocarbon group optionally having a substituent, annacyl group or a hydroxy group having a substituent; R 1b nis a hydrogen atom, a halogen atom, a hydrocarbon groupnoptionally having a substituent, an acyl group or anhydroxy group optionally having a substituent); Ar 1 andnAr 2 are independently an aromatic group optionallynhaving a substituent, and may form a condensed ringngroup with an adjacent carbon atom; Ring B is annitrogen-containing heterocycle optionally having ansubstituent; X and Y, whether identical or not, are anbond, an oxygen atom, S(O)p (p is an integer from 0 ton2), NR 4 wherein R 4 is a hydrogen atom or a lower alkylngroup, or a divalent linear lower hydrocarbon groupnwhich may have a substituent, and which may contain 1nto 3 hetero atoms; R 2 and R 3 , whether identical or not,nare a hydrogen atom, a halogen atom, a hydrocarbonngroup optionally having a substituent, an acyl group orna hydroxy group optionally having a substituent; R 7 isna hydrogen atom, a hydroxy group which may bensubstituted by lower alkyl or a carboxyl group;nprovided that Ring B is not a heterocycle representednby the formula: n nwherein r is 0 or 1, or a salt thereof, or a pro-drugnthereof exhibits anti-allergic activity, anti-histaminicnactivity and/or eosinophil chemotaxis-inhibitingnactivity, anti-inflammatory activity, anti-PAFn(platelet-activating factor) activity, and the like,nand is useful as an agent for preventing or treatingnasthma, allergic conjunctivitis allergic rhinitis,nurticaria, atopic dermatitis, and the like. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005063761-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7378418-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005063762-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7816357-B2 |
| priorityDate | 1998-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 587.